ENFINIT PLATFORM FOR CAR-T Trademark

Trademark Overview


On Tuesday, September 14, 2021, a trademark application was filed for ENFINIT PLATFORM FOR CAR-T with the United States Patent and Trademark Office. The USPTO has given the ENFINIT PLATFORM FOR CAR-T trademark a serial number of 79330693. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, December 17, 2024. This trademark is owned by MNEMO THERAPEUTICS. The ENFINIT PLATFORM FOR CAR-T trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacturing of antigens, antibodies, T-cells; Providing medical information relating to immunotherapy; information, advice and consulting services related to the field of pharmaceutical products manufacturing

Pharmaceutical products for use in the fields of oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; pharmaceutical antigens, antibodies, and cells for therapeutic use

Biological and chemical preparations for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions

Providing medical information relating to immunotherapy

Scientific research services, namely medical research; scientific research and product development, namely, identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information on immunotherapy; providing scientific research services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific analysis, namely, epigenetic antigen screening and identification services for therapeutic research purposes; scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for analyzing cells...

General Information


Serial Number79330693
Word MarkENFINIT PLATFORM FOR CAR-T
Filing DateTuesday, September 14, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacturing of antigens, antibodies, T-cells; Providing medical information relating to immunotherapy; information, advice and consulting services related to the field of pharmaceutical products manufacturing
Goods and ServicesPharmaceutical products for use in the fields of oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; pharmaceutical antigens, antibodies, and cells for therapeutic use
Goods and ServicesBiological and chemical preparations for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions
Goods and ServicesProviding medical information relating to immunotherapy
NOT AVAILABLE"PLATFORM FOR CAR-T"
Goods and ServicesScientific research services, namely medical research; scientific research and product development, namely, identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information on immunotherapy; providing scientific research services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific analysis, namely, epigenetic antigen screening and identification services for therapeutic research purposes; scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMNEMO THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 17, 2022ASSIGNED TO EXAMINER
Friday, June 17, 2022NON-FINAL ACTION WRITTEN
Saturday, June 18, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 6, 2022REFUSAL PROCESSED BY MPU
Wednesday, July 6, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 26, 2022REFUSAL PROCESSED BY IB
Wednesday, December 7, 2022CORRECTION CREATED FOR IB
Wednesday, December 7, 2022CORRECTION CREATED FOR IB
Monday, December 12, 2022CORRECTION SENT TO IB
Monday, December 12, 2022CORRECTION SENT TO IB
Thursday, January 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, January 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 9, 2023SUSPENSION LETTER WRITTEN
Monday, January 9, 2023LETTER OF SUSPENSION E-MAILED
Monday, January 9, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, March 5, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, April 11, 2023CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Tuesday, April 11, 2023ATTORNEY REVIEW COMPLETED
Wednesday, July 12, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 9, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, December 17, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, March 5, 2023USPTO CORRECTION PROCESSED BY IB
Sunday, March 5, 2023USPTO CORRECTION PROCESSED BY IB
Saturday, August 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB